5-HTTLPR-rs25531 and Antidepressant Treatment Outcomes in Korean Patients with Major Depression
Authors:
- 12 May 2021
- journal article
- research article
- Published by Georg Thieme Verlag KG in Pharmacopsychiatry
- Vol. 54 (06) , 269-278
Abstract
Introduction Despite the ethnic differences in 5-HTTLPR (S allele relates to better antidepressant response in Korean and Japanese people, while L allele with better response in Caucasians), it is unclear whether 5-HTTLPR and its high expression locus rs25531 are interactively associated with antidepressant treatment outcome. We investigated the individual and interaction effects of these polymorphisms on antidepressant treatment outcomes in the Korean population. Methods A total of 464 Korean subjects with major depressive disorder completed 6 weeks of antidepressant monotherapy. Venous blood was extracted for genotyping 5-HTTLPR and rs25531 by polymerase chain reaction and DNA sequencing. We used logistic regression analyses to verify the main and interaction effects of 5-HTTLPR and rs25531 on response and remission after antidepressant treatment. Results After adjusting for covariates, the SS genotype of 5-HTTLPR was significantly associated with better treatment outcomes (p<0.001, odds ratio [OR] [95% confidence interval (CI)]=2.435 [1.551, 3.823] in response; p0.05). Discussion Our findings suggest variations in allelic frequency and functionality of 5-HTTLPR and rs25531 among the different ethnicities. We found a minor advantage of rs25531 in achieving remission. However, there was no interaction effect with 5-HTTLPR.Keywords
Funding Information
- National Research Foundation (2020R1A2C2101276)
- National Research Foundation (2016R1A6A3A11930978)
This publication has 37 references indexed in Scilit:
- Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health’s Collaborative Center for Genomic StudiesTranslational Psychiatry, 2013
- Pharmacogenomics of antidepressants: what is next?Molecular Psychiatry, 2010
- The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptomsDepression and Anxiety, 2010
- 5-HTTLPR modulates antidepressant efficacy in depressed womenPsychiatric Genetics, 2009
- Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depressionEuropean Neuropsychopharmacology, 2009
- SLC6A4 variation and citalopram responseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Recent developments and current controversies in depressionThe Lancet, 2006
- The choice of a genetic model in the meta-analysis of molecular association studiesInternational Journal of Epidemiology, 2005
- Detecting Marker-Disease Association by Testing for Hardy-Weinberg Disequilibrium at a Marker LocusThe American Journal of Human Genetics, 1998
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987